5H: Postdoctoral Research Award

Date: Friday, March 27, 2026
Time: 8:00 AM to 10:00 AM

Room: GH East CD

Description

The goal of the SFB-PRA is to recognize excellence in future leaders of biomaterials and provide a platform to present their work to faculty and potential recruiters. Finalist will present at the PRA competition and the award recipients will be selected upon the quality and presentation of their work.

Moderators:

Claudia Loebel, M.D. Ph.D. | Assistant Professor, University of Pennsylvania
Fan Zhang, M.D. | Professor, University of Washington

8:00 AM. 271. Microblasting Patch Disrupts Bacterial Barriers Mechanically to Treat Polymicrobial Biofilm-Mediated Wounds.
8:15 AM. 272. Screening Salivary Gland-Acting Drugs to Control Oral Biofilm Virulence via the Salivary Gland Mimetic Tissue Chip.Sydney Yang, PhD1, Lisa DeLouise, PhD, MPD2, Danielle Benoit1 1University of Oregon, 2University of Rochester
8:30 AM. 273. Structurally Anisotropic Microgel Particles (STAMPs) Regulate Cellular Invasion and Angiogenesis
9:00 AM. 275. Engineering Organelle-Based Therapeutics: Controlled Mitochondrial Transfer for Bone Repair
9:15 AM. 276. Enhanced Dynamic Covalent Chemistry for Controlled Drug Release from Supramolecular Hydrogels
9:30 AM. A Precisely Controlled Long-Acting Immunosuppression Platform Enables Prolonged Survival of Vascularized Composite Allografts
9:45 AM. 278. Shaping Vaccine Immune Responses Through mRNA Lipid Nanoparticle Design
B8:45 AM. 274. io-Hybrid Electro-Osmotic Pumping Platform for Active Lymphatic Rerouting in Lymphedema

Description

8:00 AM. 271. Microblasting Patch Disrupts Bacterial Barriers Mechanically to Treat Polymicrobial Biofilm-Mediated Wounds.

8:15 AM. 272. Screening Salivary Gland-Acting Drugs to Control Oral Biofilm Virulence via the Salivary Gland Mimetic Tissue Chip.Sydney Yang, PhD1, Lisa DeLouise, PhD, MPD2, Danielle Benoit1 1University of Oregon, 2University of Rochester

8:30 AM. 273. Structurally Anisotropic Microgel Particles (STAMPs) Regulate Cellular Invasion and Angiogenesis

9:00 AM. 275. Engineering Organelle-Based Therapeutics: Controlled Mitochondrial Transfer for Bone Repair

9:15 AM. 276. Enhanced Dynamic Covalent Chemistry for Controlled Drug Release from Supramolecular Hydrogels

9:30 AM. A Precisely Controlled Long-Acting Immunosuppression Platform Enables Prolonged Survival of Vascularized Composite Allografts

9:45 AM. 278. Shaping Vaccine Immune Responses Through mRNA Lipid Nanoparticle Design

B8:45 AM. 274. io-Hybrid Electro-Osmotic Pumping Platform for Active Lymphatic Rerouting in Lymphedema